EVGN:NASDAQ
Evogene Ltd
0,37 USD
arrow_upward
+0,98%(+0,0036) 1G
20 ott, 16:00:01 GMT-4 · USD
search
Tutti i simboli
| Simbolo | Prezzo | Cambio | % di cambio |
|---|
insights_autoGenerazione degli insight principali per EVGN in corso…
Apertura
0,39 USD
Massimo
0,39 USD
Minimo
0,37 USD
Cap. mercato
6,67 Mln
Vol. medio
2,57 Mln
Volume
11,12K
Max 52 sett.
1,33 USD
Min 52 sett.
0,35 USD
Utili per azione
-0,90 USD
Beta
1,44
Azioni in circolazione
18,05 Mln
N. di dipendenti
52
Apertura
0,39 USD
Massimo
0,39 USD
Minimo
0,37 USD
Cap. mercato
6,67 Mln
Vol. medio
2,57 Mln
Volume
11,12K
Max 52 sett.
1,33 USD
Min 52 sett.
0,35 USD
Utili per azione
-0,90 USD
Beta
1,44
Azioni in circolazione
18,05 Mln
N. di dipendenti
52
Articoli giornalistici
Da fonti web e partner giornalistici
Profilo
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
Informazioni su Evogene Ltd